What should I do if my aspartate aminotransferase is too high?

If the aspartate aminotransferase level is high, you need to pay attention and choose the correct coping method, such as using some liver-protecting and enzyme-lowering drugs. However, you should pay attention to the use of drugs or some treatment courses, and you should listen to the doctor's advice.

First, choose correct and effective liver-protecting and enzyme-lowering drugs. For the treatment of elevated aspartate aminotransferase caused by various causes, the effective drugs are mainly traditional Chinese medicine and extracts of its active ingredients. Generally, drugs containing chemical ingredients such as schisandra chinensis vine, glycyrrhizic acid, oleanolic acid, and silymarin are selected. Liuwei Wuling Tablets are composed of drugs such as Schisandra chinensis, Licorice, and Forsythia suspensa. They have the effects of nourishing the liver and kidneys, detoxifying and removing dampness. They can be used to treat various chronic hepatitis patients with elevated aspartate aminotransferase. It is a new generation of liver-protecting and enzyme-lowering therapeutic drugs and has been widely used in clinical practice. As long as patients use the above enzyme-lowering drugs correctly, aspartate aminotransferase can be effectively controlled, and the enzyme-lowering treatment effect is long-lasting and stable. For patients who are using nucleoside (acid) analogs for the first time, it is recommended to use drugs with high antiviral activity and low drug resistance. Entecavir tablets can quickly reduce blood HBV DNA levels. After 12 weeks of treatment, the virus can be reduced by more than 5 times. After 48 weeks of treatment, the HBV DNA level in 75% of patients can be reduced to below the detection level. Studies have shown that under the same treatment conditions, entecavir tablets represented by Runzhong are the fastest antiviral drugs that can achieve virological conversion to negative among existing antiviral drugs.

Second, the course of treatment must be guaranteed. When enzyme-lowering drugs restore aspartate aminotransferase to normal, the dosage of enzyme-lowering drugs should be gradually reduced, and sudden discontinuation of the drug should be avoided. The course of treatment with enzyme-lowering drugs should be more than 1 year, and even if liver function returns to normal, consolidation treatment should be maintained at the lowest level. For example, if intravenous drip of glycyrrhizin is used to lower enzymes, after liver function returns to normal, daily infusion can be changed to infusion every other day, and then every two days. If oral enzyme-lowering drugs are used as a substitute, it is best to choose strong drugs such as Liuwei Wuling Tablets, and successfully switch from infusion to oral administration.

Third, while protecting the liver and reducing enzymes, it is necessary to take "fundamental" measures to address the cause of the disease. For example, treatment of hepatitis B requires both antiviral and immunomodulatory therapy. Treating hepatitis B is a global problem. Currently, the best way is combination medication and comprehensive management, which is the so-called "treating both the symptoms and the root causes." Antiviral treatment is the root cause and the basis of treatment. Although there is no specific drug for the treatment of hepatitis B, there are some effective drugs. The drugs that represent the latest research results are new nucleoside antiviral drugs - Adefovir, Entecavir, Telbivudine, etc. Long-acting interferon is also one of the main drugs for the treatment of hepatitis B. Hepatitis B patients need to cooperate with antiviral treatment while undergoing liver protection and enzyme lowering treatment. After long-term effective treatment, the patient's laboratory tests showed that all hepatitis B virus replication indicators turned negative, and serological conversion occurred between hepatitis B virus e antigen and e antibody. This means that the condition has improved fundamentally and aspartate aminotransferase has the possibility of achieving long-term stability.

Fourth, in the treatment of hepatitis C, the first consideration is the use of interferon combined with ribavirin for antiviral treatment, and at the same time combined with liver-protecting and enzyme-lowering drugs such as Liuwei Wuling Tablets, with a course of treatment of more than 1 year. Patients with autoimmune hepatitis need to use immunosuppressants in combination with liver-protecting and enzyme-lowering drugs such as Liuwei Wuling Tablets, and the treatment course is more than one year. For alcoholic liver, fatty liver, etc., you first need to quit drinking, improve your diet, lose weight, and at the same time use liver-protecting and enzyme-lowering drugs such as Liuwei Wuling tablets. In short, in order to solve the problem of high aspartate aminotransferase levels, we must find out the reasons and prescribe the right medicine to achieve results.